Omeprazol (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Omeprazol" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
2nd place
3rd place
924th place
87th place
68th place
29th place
low place
1,805th place
8,614th place
583rd place
low place
low place
1st place
1st place

aok-beratungsapotheker.de

apotheke-adhoc.de

  • Apotheke Adhoc (Hrsg.): Demenz durch Omeprazol. 18. Februar 2016 (apotheke-adhoc.de [abgerufen am 9. Oktober 2017]).

doi.org

  • C. Reimer, B. Søndergaard, L. Hilsted, P. Bytzer: Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. In: Gastroenterology. Band 137, Nummer 1, Juli 2009, S. 80–7, 87.e1, doi:10.1053/j.gastro.2009.03.058. PMID 19362552.
  • T. Makunts, I. V. Cohen, L. Awdishu, R. Abagyan: Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis. In: Nature Scientific Report. 9, 2019, S. 2282, Published online 2019 Feb 19, doi:10.1038/s41598-019-39335-7. PMID 30783195.
  • S. Šutalo, M. Ruetten, S. Hartnack, C. E. Reusch, P. H. Kook: The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats. In: Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. Band 29, Nummer 3, Mai-Jun 2015, S. 840–846, doi:10.1111/jvim.12580. PMID 25966746.
  • B. W. Sykes, M. Hewetson, R. J. Hepburn, N. Luthersson, Y. Tamazali: ECEIM Consensus Paper - Equine Gastric Ulcer Syndrom in adult horses. In: Journal of Veterinary Internal Medicine. 2015, doi:10.1111/jvim.13578.
  • Lars Olbe, Enar Carlsson, Per Lindberg: A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. In: Nature Reviews Drug Discovery. Band 2, Nr. 2, 2003, S. 132–139, doi:10.1038/nrd1010, PMID 12563304.

europa.eu

ema.europa.eu

nih.gov

ncbi.nlm.nih.gov

  • J. Labenz, K. U. Petersen, W. Rösch, H. R. Koelz: A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole. In: Aliment Pharmacol Ther. 17(8), Apr 2003, S. 1015–1019. PMID 12694083.
  • C. Reimer, B. Søndergaard, L. Hilsted, P. Bytzer: Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. In: Gastroenterology. Band 137, Nummer 1, Juli 2009, S. 80–7, 87.e1, doi:10.1053/j.gastro.2009.03.058. PMID 19362552.
  • T. Makunts, I. V. Cohen, L. Awdishu, R. Abagyan: Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis. In: Nature Scientific Report. 9, 2019, S. 2282, Published online 2019 Feb 19, doi:10.1038/s41598-019-39335-7. PMID 30783195.
  • S. Šutalo, M. Ruetten, S. Hartnack, C. E. Reusch, P. H. Kook: The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats. In: Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. Band 29, Nummer 3, Mai-Jun 2015, S. 840–846, doi:10.1111/jvim.12580. PMID 25966746.
  • Lars Olbe, Enar Carlsson, Per Lindberg: A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. In: Nature Reviews Drug Discovery. Band 2, Nr. 2, 2003, S. 132–139, doi:10.1038/nrd1010, PMID 12563304.

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

pharmazeutische-zeitung.de

sigmaaldrich.com

web.archive.org